Advertisement
Screener

Acumen Pharmaceuticals, Inc. (ABOS) Auditor

Acumen Pharmaceuticals, Inc. Auditor

The independent registered public accounting firm that signed the audit report in each annual report on Form 10-K, newest first. PCAOB firm ID and the internal-control attestation are as tagged on the cover from fiscal 2021; earlier rows come from the signed report text.

  • 2026-03-26: Fiscal year end 2025-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Philadelphia, Pennsylvania.
  • 2025-03-27: Fiscal year end 2024-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Philadelphia, Pennsylvania.
  • 2024-03-26: Fiscal year end 2023-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Tysons, Virginia.
  • 2023-03-27: Fiscal year end 2022-12-31; Auditor Ernst & Young LLP; PCAOB firm ID 42; Location Tysons, Virginia.
FiledFiscal year endAuditorPCAOB firm IDLocationInternal-control attestation
2026-03-262025-12-31Ernst & Young LLP42Philadelphia, PennsylvaniaNo
2025-03-272024-12-31Ernst & Young LLP42Philadelphia, PennsylvaniaNo
2024-03-262023-12-31Ernst & Young LLP42Tysons, VirginiaNo
2023-03-272022-12-31Ernst & Young LLP42Tysons, VirginiaNo
2022-03-282021-12-31Ernst & Young LLP42Tysons, VirginiaNo

Similar stocks

Stock NameCountryMarket CapPE Ratio
Outlook Therapeutics, Inc. (OTLK)United States$0.162B-4.90
Humacyte, Inc. (HUMA)United States$0.155B-2.26
Voyager Therapeutics, Inc. (VYGR)United States$0.173B-1.99
PRECISION BIOSCIENCES INC (DTIL)United States$0.175B-3.95
Coherus Oncology, Inc. (CHRS)United States$0.182B-1.63
Tenaya Therapeutics, Inc. (TNYA)United States$0.140B-1.60
Alpha Cognition Inc. (ACOG)$0.185B-6.77
Caribou Biosciences, Inc. (CRBU)United States$0.134B-1.79
Armata Pharmaceuticals, Inc. (ARMP)United States$0.132B
Neumora Therapeutics, Inc. (NMRA)United States$0.132B-1.48